Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/26 16:05 | 5/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 2 | S | -6 | 17.00 | 0 | 0 | 0 | 155 | D | ||||||||||||||
5/14/26 16:04 | 5/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 2 | S | -42 | 17.09 | 0 | -2 | 172 | D | |||||||||||||||
5/14/26 16:03 | 5/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Lucera Erick | MA | O | CFO | 2 | S | -133 | 18.58 | 0 | -7 | 125 | D | |||||||||||||||
5/14/26 16:02 | 5/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 2 | S | -101 | 16.80 | 0 | -6 | 446 | D | |||||||||||||||
5/6/26 17:09 | 5/4/26 | DYN | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | 4 | S.m | -29,693 | 19.12 | 0 | -1,553 | 1,286 | I | ||||||||||||||||
4/23/26 16:15 | 4/21/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | D | 5 | S.m | -24,741 | 19.54 | 0 | -1,266 | 4,774 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |